Royalty Period. The royalty payments set forth above shall be payable for each Licensed Product on a product-by-product and country-by-country basis from the time of First Commercial Sale of Licensed Product in such country until the later of (i) [**] years from the time of First Commercial Sale of Licensed Product in such country or (ii) until the last to expire patent containing a Valid Claim providing marketing exclusivity with respect to such Licensed Product.
Appears in 2 contracts
Samples: Collaborative Discovery and Lead Optimization Agreement (3 Dimensional Pharmaceuticals Inc), Collaborative Discovery and Lead Optimization Agreement (3 Dimensional Pharmaceuticals Inc)
Royalty Period. The royalty payments set forth above shall be payable for each Licensed Product on a product-by-product and country-by-by- country basis from the time of First Commercial Sale of Licensed Product in such country until the later of of: (ia) [**] ten (10) years from the time of First Commercial Sale of Licensed Product in such country country; or (iib) until the last to last-to-expire patent or -lapse of Patent Rights containing a Valid Claim providing marketing exclusivity with respect to the Active Compound which is an ingredient of such Licensed ProductProduct in such country.
Appears in 2 contracts
Samples: Drug Discovery Collaboration Agreement (3 Dimensional Pharmaceuticals Inc), Drug Discovery Collaboration Agreement (3 Dimensional Pharmaceuticals Inc)
Royalty Period. The royalty payments set forth above in Section 5.9 shall be payable for each Licensed Product on a product-by-product and country-by-country basis from the time of First Commercial Sale of Licensed Product in such country until the later of of: (ia) [** *] years from the time of First Commercial Sale of Licensed Product in such country country; or (iib) until the last to last-to-expire patent or -lapse of Patent Rights containing a Valid Claim providing marketing exclusivity with respect to the Active Compound (including without limitation a Replacement Compound) which is an ingredient of such Licensed ProductProduct in such country.
Appears in 1 contract
Samples: Collaboration Agreement (3 Dimensional Pharmaceuticals Inc)
Royalty Period. The royalty payments set forth above shall be payable for each Licensed Product on a product-by-product and country-by-country basis from the time of First Commercial Sale of Licensed Product in such country until the later of (i) [**] 10 years from the time of First Commercial Sale of Licensed Product in such country or (ii) until the last to expire patent containing a Valid Claim providing marketing exclusivity with respect to such Licensed Product.
Appears in 1 contract
Samples: Collaborative Discovery and Lead Optimization Agreement (3 Dimensional Pharmaceuticals Inc)
Royalty Period. The royalty payments set forth above shall be payable for each Licensed Product on a product-by-product and country-by-country basis from the time of First Commercial Sale of such Licensed Product in such country until the later of (i) [**] 10 years from the time of First Commercial Sale of such Licensed Product in such country or (ii) until the last to expire patent Patent containing a Valid Claim providing marketing exclusivity with respect to that covers the making, using, or selling of such Licensed ProductProduct in such country.
Appears in 1 contract
Samples: Collaborative Discovery and Lead Optimization Agreement (3 Dimensional Pharmaceuticals Inc)
Royalty Period. The royalty payments set forth above shall be payable for each Licensed Product on a product-by-product and country-by-country basis from the time date of First Commercial Sale of such Licensed Product in such country until the later of of: (ia) [**] years from the time date of First Commercial Sale of such Licensed Product in such country country; or (iib) until the last to expire patent containing a Valid Claim providing marketing exclusivity with respect to such Licensed Product[**].
Appears in 1 contract
Samples: Research and Development (3 Dimensional Pharmaceuticals Inc)